PanARMENIAN.Net - The NHS in the United Kingdom is going to trial a breath test that uses artificial intelligence and operates at the ‘nanoparticles’ level to detect a range of diseases, Metro says.
The "electronic nose" technology will look for chemicals (‘biomarkers’ ) that are produced by a number of conditions, including cancer, dementia and TB. The new breath test will be more sensitive (and therefore accurate) than the current ones being used.
The first human trials are scheduled at two NHS hospitals and two US hospitals in autumn and will look for lung cancer in patients. Test subjects will breath through a mouthpiece for a minute before the sample is processed by a machine on site.
The information will then be relayed to a supercomputer at developer Ancon Medical’s HQ, in Kent, ...
Read full story
